Korean Drug Co., Ltd. (KOSDAQ:014570)
South Korea
· Delayed Price · Currency is KRW 4,295.00
-15.00 (-0.35%)
At close: Dec 4, 2025
Korean Drug Revenue
Korean Drug had revenue of 16.49B KRW in the quarter ending September 30, 2025, a decrease of -3.12%. This brings the company's revenue in the last twelve months to 62.21B, down -16.39% year-over-year. In the year 2024, Korean Drug had annual revenue of 73.00B, down -10.29%.
Revenue (ttm)
62.21B
Revenue Growth
-16.39%
P/S Ratio
0.75
Revenue / Employee
230.42M
Employees
270
Market Cap
46.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 73.00B | -8.37B | -10.29% |
| Dec 31, 2023 | 81.37B | 1.39B | 1.74% |
| Dec 31, 2022 | 79.98B | 5.52B | 7.41% |
| Dec 31, 2021 | 74.47B | 7.68B | 11.49% |
| Dec 31, 2020 | 66.79B | 11.26B | 20.28% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| KB Financial Group | 14.89T |
| HD Hyundai Heavy Industries | 16.39T |